| Autor: |
J H, Check, A, Rosenberg, D L, Check, A, DiAntonio, H, Rui, R, Cohen, G, DiAntonio |
| Rok vydání: |
2018 |
| Předmět: |
|
| Zdroj: |
Clinical and experimental obstetricsgynecology. 44(2) |
| ISSN: |
0390-6663 |
| Popis: |
To determine if serum levels of the immunomodulatory protein, the progesterone induced blocking factor (PIBF), which is present in high levels during normal pregnancy, is present in higher levels in women with breast cancer positive for progesterone receptors. The study would also determine whether the presence or absence of the estrogen receptor in any way modifies PIBF expression.PIBF using a research ELISA was evaluated in the follicular phase in 21 women with receptor status as follows: seven with estrogen receptor (ER)+ and progesterone receptor (PR)+, seven with ER- and PR+, and seven with ER+ and PR.The results showed no differences in serum PIBF in the three groups. The serum PIBF levels were no different than historical controls in the follicular phase.Measurement of serum PIBF does not seem to be an important marker to use to either detect women with breast cancer or to help determine tumor virulence or potential specific therapies. If PIBF plays a role in helping cancer cells to escape immune surveillance, it seems that the intracytoplasmic PIBF would be the form most likely operative. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
